These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15454294)

  • 21. Photo-assisted gene delivery using light-responsive catanionic vesicles.
    Liu YC; Le Ny AL; Schmidt J; Talmon Y; Chmelka BF; Lee CT
    Langmuir; 2009 May; 25(10):5713-24. PubMed ID: 19435291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattle.
    van Drunen Littel-van den Hurk S; Luxembourg A; Ellefsen B; Wilson D; Ubach A; Hannaman D; van den Hurk JV
    Vaccine; 2008 Oct; 26(43):5503-9. PubMed ID: 18708108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice.
    Jiang L; Qian F; He X; Wang F; Ren D; He Y; Li K; Sun S; Yin C
    J Gene Med; 2007 Apr; 9(4):253-64. PubMed ID: 17397104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
    Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W
    Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant.
    Zhang L; Widera G; Rabussay D
    Bioelectrochemistry; 2004 Jun; 63(1-2):369-73. PubMed ID: 15110305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen.
    Gregoriadis G; Tan L; Ben-Ahmeida ET; Jennings R
    Vaccine; 1992; 10(11):747-53. PubMed ID: 1441730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin.
    Mann JF; Ferro VA; Mullen AB; Tetley L; Mullen M; Carter KC; Alexander J; Stimson WH
    Vaccine; 2004 Jun; 22(19):2425-9. PubMed ID: 15193405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cationic liposomes/DNA charge ratio on gene expression and antibody response of a candidate DNA vaccine against Maedi Visna virus.
    Henriques AM; Madeira C; Fevereiro M; Prazeres DM; Aires-Barros MR; Monteiro GA
    Int J Pharm; 2009 Jul; 377(1-2):92-8. PubMed ID: 19446620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
    Alpar HO; Somavarapu S; Atuah KN; Bramwell VW
    Adv Drug Deliv Rev; 2005 Jan; 57(3):411-30. PubMed ID: 15560949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity.
    Mann JF; Scales HE; Shakir E; Alexander J; Carter KC; Mullen AB; Ferro VA
    Methods; 2006 Feb; 38(2):90-5. PubMed ID: 16414269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
    O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
    Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanism of naked DNA uptake and expression.
    Wolff JA; Budker V
    Adv Genet; 2005; 54():3-20. PubMed ID: 16096005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression.
    Bins AD; Jorritsma A; Wolkers MC; Hung CF; Wu TC; Schumacher TN; Haanen JB
    Nat Med; 2005 Aug; 11(8):899-904. PubMed ID: 15965482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques.
    Hirao LA; Wu L; Khan AS; Satishchandran A; Draghia-Akli R; Weiner DB
    Vaccine; 2008 Jan; 26(3):440-8. PubMed ID: 18082294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine.
    Wilson KD; de Jong SD; Kazem M; Lall R; Hope MJ; Cullis PR; Tam YK
    J Gene Med; 2009 Jan; 11(1):14-25. PubMed ID: 19003796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B.
    Dutta T; Garg M; Jain NK
    Vaccine; 2008 Jun; 26(27-28):3389-94. PubMed ID: 18511160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
    Anderson RJ; Schneider J
    Vaccine; 2007 Sep; 25 Suppl 2():B24-34. PubMed ID: 17698262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.